PE-Backed UnisLink Acquires AQREVA and Doctors’ Resource Specialists

PE-Backed UnisLink Acquires AQREVA and Doctors’ Resource Specialists

UnisLink, a portfolio company of Boston-based private equity firm Riverside Partners, has announced the acquisition of AQREVA and Doctors’ Resource Specialists (DRS). This strategic acquisition strengthens UnisLink’s position as a comprehensive provider of revenue cycle management (RCM) solutions and expands the company’s geographic reach. Based in Sioux Falls, South Dakota, AQREVA is a professional services company offering comprehensive medical billing and RCM related services. DRS is a medical billing, medical coding and reimbursement consulting company based in Phoenix, Arizona. UnisLink is a national leader in RCM and population health management services for... Read More »
PE-Backed UnisLink Acquires RCM Provider HST

PE-Backed UnisLink Acquires RCM Provider HST

UnisLink has announced its acquisition of Healthcare Support Technologies (HST), a revenue cycle management (RCM) solutions provider based in New Brighton, Pennsylvania. HST provides medical billing, credentialing and medical coding services to independent physician practices, federally qualified health centers, rural health clinics and regional health systems across the United States. UnisLink, a portfolio company of Boston-based private equity firm Riverside Partners, is a national leader in revenue cycle and population health management services for independent physician practices. HST strengthens UnisLink’s position as a comprehensive provider of RCM solutions and expands the... Read More »
CROs Are Still Trending as Q4 Rolls On

CROs Are Still Trending as Q4 Rolls On

In the first week of November, BioAgilytix Labs, LLC, a portfolio company of Riverside Partners, purchased Cambridge Biomedical. Both Cambridge and BioAgilytix are contract research organizations (CROs) that develop novel therapeutic biologics and biosimilars, specializing in large molecule bioanalysis. The transaction expands BioAgilytix’s global footprint and adds further capacity by joining Cambridge Biomedical’s CLIA-certified, CAP-accredited, and GLP-compliant facility with its GxP laboratories in Durham, North Carolina and Hamburg, Germany. It also gives BioAgilytix a total of 400 employees. The merger follows a busy October for CROs, in which five deals were reported, accounting for... Read More »
Home Health & Hospice Deals Kick Off 2019

Home Health & Hospice Deals Kick Off 2019

The Home Health & Hospice sector is predicted to see a great deal more mergers and acquisitions in 2019 than it has in recent years. Bullish industry watchers cite the growing momentum behind value-based health care delivered in lower-cost settings as just one tailwind that is expected to boost the sector. This sector closed out 2018 with 82 deals in our database, the best year for M&A since 2014, when 81 deals were made public. Four deals are already on the books, all announced in the first week of the new year. Three are from private equity sponsors or their platform companies. One deal echoed a growing trend of joint ventures between not-for-profit health systems and for-profit... Read More »

CROs Are Back, Many with Specialties

We’ve documented the increase in biotechnology acquisitions and license deals by pharmaceutical companies in previous posts. But the impact of pharma’s move away from in-house R&D has benefited other sectors of the healthcare industry, particularly clinical research organizations (CROs). For those outside the technology side of healthcare, CROs provide outsourced research services to the pharmaceutical, biotechnology, and medical device industries on a contract basis. Through mid-November, we’ve seen an increase of 325% in deal volume for CROs, compared with the year before. In 2015, just five deals for these targets were announced. So far this year, 17 are on the... Read More »